Detalhe da pesquisa
1.
A first-in-human study of the novel immunology antibody-drug conjugate, ABBV-3373, in healthy participants.
Br J Clin Pharmacol
; 90(1): 189-199, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596703
2.
Brain tumour cells interconnect to a functional and resistant network.
Nature
; 528(7580): 93-8, 2015 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26536111
3.
Tweety-Homolog 1 Drives Brain Colonization of Gliomas.
J Neurosci
; 37(29): 6837-6850, 2017 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607172
4.
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.
Proc Natl Acad Sci U S A
; 111(1): 409-14, 2014 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24367102
5.
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.
Glia
; 63(1): 78-90, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132599
6.
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
J Neurochem
; 131(2): 251-64, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24976529
7.
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis.
Clin Pharmacokinet
; 62(4): 623-634, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905528
8.
A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum.
Bioanalysis
; 13(7): 537-549, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33729007
9.
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.
Mol Cancer Res
; 16(5): 767-776, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29453321
10.
NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
Cancer Lett
; 380(2): 568-576, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26297987
11.
Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.
Clin Cancer Res
; 22(24): 6078-6087, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521448
12.
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.
Oncotarget
; 7(35): 56713-56725, 2016 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27447560
13.
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget
; 7(50): 82028-82045, 2016 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27880937
14.
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Oncotarget
; 6(31): 31050-68, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682871
15.
Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival.
Cell Stem Cell
; 15(2): 185-98, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24835569
16.
mTORC 2:1 for chemotherapy sensitization in glioblastoma.
Cancer Discov
; 1(6): 475-6, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22586651